{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:54:43Z","timestamp":1740160483746,"version":"3.37.3"},"reference-count":5,"publisher":"Walter de Gruyter GmbH","issue":"7","funder":[{"DOI":"10.13039\/100015758","name":"Novo Nordisk Pharma Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015758","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100019522","name":"JCR Pharmaceuticals Co., Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019522","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,26]]},"DOI":"10.1515\/jpem-2023-0217","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T14:30:28Z","timestamp":1685716228000},"page":"697-699","source":"Crossref","is-referenced-by-count":1,"title":["Potential usefulness of assessing serum betamethasone levels during betamethasone therapy"],"prefix":"10.1515","volume":"36","author":[{"given":"Makiko","family":"Yano","sequence":"first","affiliation":[{"name":"Department of Pediatrics , Keio University School of Medicine , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0535-2975","authenticated-orcid":false,"given":"Takeshi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Keio University School of Medicine , Tokyo , Japan"},{"name":"Department of Pediatrics , Shin-Yurigaoka General Hospital , Kawasaki , Kanagawa , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satsuki","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Keio University School of Medicine , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Shimozato","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Shin-Yurigaoka General Hospital , Kawasaki , Kanagawa , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7360-2465","authenticated-orcid":false,"given":"Tomohiro","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Keio University School of Medicine , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonobu","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Keio University School of Medicine , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"2023070813115016413_j_jpem-2023-0217_ref_001","doi-asserted-by":"crossref","unstructured":"Ali, T, Habib, A, Zohair, M, Aman, L. Betamethasone cream to treat diapers rash causing Cushing syndrome. J Pediatr Endocrinol Metab 2023;36:414\u20137. https:\/\/doi.org\/10.1515\/jpem-2022-0415.","DOI":"10.1515\/jpem-2022-0415"},{"key":"2023070813115016413_j_jpem-2023-0217_ref_002","doi-asserted-by":"crossref","unstructured":"Mizuchi, A, Okada, N, Henmi, Z, Miyachi, Y. Radioimmunoassay for plasma betamethasone 17-benzoate. Steroids 1975;26:635\u201345. https:\/\/doi.org\/10.1016\/0039-128x(75)90056-2.","DOI":"10.1016\/0039-128X(75)90056-2"},{"key":"2023070813115016413_j_jpem-2023-0217_ref_003","doi-asserted-by":"crossref","unstructured":"Inoue, D, Tanaka, A, Kimura, S, Kiriyama, A, Katsumi, H, Yamamoto, A, et al.. The relationship between in\u00a0vivo nasal drug clearance and in\u00a0vitro nasal mucociliary clearance: application to the prediction of nasal drug absorption. Eur J Pharmaceut Sci 2018;117:21\u20136. https:\/\/doi.org\/10.1016\/j.ejps.2018.01.032.","DOI":"10.1016\/j.ejps.2018.01.032"},{"key":"2023070813115016413_j_jpem-2023-0217_ref_004","doi-asserted-by":"crossref","unstructured":"Petersen, MC, Nation, RL, McBride, WG, Ashley, JJ, Moore, RG. Pharmacokinetics of betamethasone in healthy adults after intravenous administration. Eur J Clin Pharmacol 1983;25:643\u201350. https:\/\/doi.org\/10.1007\/bf00542353.","DOI":"10.1007\/BF00542353"},{"key":"2023070813115016413_j_jpem-2023-0217_ref_005","doi-asserted-by":"crossref","unstructured":"Coll, S, Monfort, N, Alechaga, \u00c9, Matabosch, X, P\u00e9rez-Ma\u00f1\u00e1, C, Ventura, R. Elimination profiles of betamethasone after different administration routes: evaluation of the reporting level and washout periods to ensure safe therapeutic administrations. Drug Test Anal 2021;13:348\u201359. https:\/\/doi.org\/10.1002\/dta.2928.","DOI":"10.1002\/dta.2928"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2023-0217\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2023-0217\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T13:13:05Z","timestamp":1688821985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2023-0217\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":5,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,5,25]]},"published-print":{"date-parts":[[2023,7,26]]}},"alternative-id":["10.1515\/jpem-2023-0217"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2023-0217","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"type":"print","value":"0334-018X"},{"type":"electronic","value":"2191-0251"}],"subject":[],"published":{"date-parts":[[2023,6,5]]}}}